Strides Pharma Science的争议事件
以下收录公开来源中与该品牌相关的争议事件。列出一条并不表示过错已经证实。
返回词条共 1 条
2020
Strides Pharma在美国召回他克莫司胶囊
宣布召回
Strides Pharma Science旗下子公司Strides Pharma Inc在美国启动召回960瓶他克莫司胶囊。此前FDA指出该产品未达到水分限度要求。FDA将此次召回列为III类。
品牌回应
召回 — Strides Pharma Inc
The company has initiated the countrywide recall of the affected lot on December 22, 2020.
来源摘录
The company has initiated the countrywide recall of the affected lot on December 22, 2020.
In a separate statement, the USFDA said Strides Pharma Inc, a subsidiary of Bengaluru-based Strides Pharma Science, is recalling 960 bottles of Tacrolimus capsules (100mg) due to "failed moisture limits".